Mixed ligand copper(ii)-diimine complexes of 2-formylpyridine-N4-phenylthiosemicarbazone: diimine co-ligands tune thein vitronanomolar cytotoxicity
- 23 May 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 52 (26) , 9148-9169
Abstract
The bpy (IC50, 7 nM) and 5,6-dmp (IC50,13.57 nM) Cu(ii) complexes exhibit phenomenal cytotoxicity.Keywords
This publication has 112 references indexed in Scilit:
- Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compoundsJBIC Journal of Biological Inorganic Chemistry, 2011
- Platinum anticancer drugs. From serendipity to rational designAnnales Pharmaceutiques Françaises, 2011
- Anticancer Activity of Metal Complexes: Involvement of Redox ProcessesAntioxidants & Redox Signaling, 2011
- Ternary Dinuclear Copper(II) Complexes of a Hydroxybenzamide Ligand with Diimine Coligands: the 5,6-dmp Ligand Enhances DNA Binding and Cleavage and Induces ApoptosisInorganic Chemistry, 2011
- Mechanisms of Cisplatin NephrotoxicityToxins, 2010
- A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503Investigational New Drugs, 2009
- Platinum Resistance: The Role of DNA Repair PathwaysClinical Cancer Research, 2008
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Preferential DNA Cleavage under Anaerobic Conditions by a DNA-Binding Ruthenium DimerInorganic Chemistry, 2007
- Molecular mechanisms of resistance and toxicity associated with platinating agentsCancer Treatment Reviews, 2007